JP2024515555A5 - - Google Patents
Info
- Publication number
- JP2024515555A5 JP2024515555A5 JP2023561628A JP2023561628A JP2024515555A5 JP 2024515555 A5 JP2024515555 A5 JP 2024515555A5 JP 2023561628 A JP2023561628 A JP 2023561628A JP 2023561628 A JP2023561628 A JP 2023561628A JP 2024515555 A5 JP2024515555 A5 JP 2024515555A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- pharmaceutical product
- formulation
- present
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171429P | 2021-04-06 | 2021-04-06 | |
| US63/171,429 | 2021-04-06 | ||
| PCT/US2022/071562 WO2022217231A1 (en) | 2021-04-06 | 2022-04-05 | Formulations of l-asparaginase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515555A JP2024515555A (ja) | 2024-04-10 |
| JP2024515555A5 true JP2024515555A5 (cg-RX-API-DMAC10.html) | 2025-04-14 |
Family
ID=81748398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561628A Pending JP2024515555A (ja) | 2021-04-06 | 2022-04-05 | Ｌ－アスパラギナーゼの製剤 |
Country Status (12)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022211829A1 (en) * | 2021-03-30 | 2022-10-06 | Jazz Pharmaceuticals Ireland Ltd. | Dosing of recombinant l-asparaginase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007103290A2 (en) | 2006-03-03 | 2007-09-13 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Materials and methods directed to asparagine synthetase and asparaginase therapies |
| DK3463308T4 (da) * | 2016-06-01 | 2026-02-09 | Servier Ip Uk Ltd | Formuleringer af polyalkylenoxid-asparaginase og fremgangsmåder til fremstilling og anvendelse deraf |
| JP2021505661A (ja) * | 2017-11-30 | 2021-02-18 | ジャズ ファーマシューティカルズ アイルランド リミテッド | アスパラギナーゼを用いた治療法 |
| CA3156066A1 (en) * | 2019-10-25 | 2021-04-29 | Mi Rim Choi | Recombinant l-asparaginase |
-
2022
- 2022-04-05 KR KR1020237037007A patent/KR20230165799A/ko active Pending
- 2022-04-05 BR BR112023019862A patent/BR112023019862A2/pt unknown
- 2022-04-05 AR ARP220100846A patent/AR125301A1/es unknown
- 2022-04-05 MX MX2023011693A patent/MX2023011693A/es unknown
- 2022-04-05 EP EP22724215.3A patent/EP4319818A1/en active Pending
- 2022-04-05 CN CN202280032191.2A patent/CN117377494A/zh active Pending
- 2022-04-05 AU AU2022256071A patent/AU2022256071A1/en active Pending
- 2022-04-05 CA CA3213726A patent/CA3213726A1/en active Pending
- 2022-04-05 WO PCT/US2022/071562 patent/WO2022217231A1/en not_active Ceased
- 2022-04-05 JP JP2023561628A patent/JP2024515555A/ja active Pending
-
2023
- 2023-10-05 CL CL2023002983A patent/CL2023002983A1/es unknown
- 2023-10-23 CO CONC2023/0014093A patent/CO2023014093A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230047111A1 (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| JP2024503265A5 (cg-RX-API-DMAC10.html) | ||
| FI4267105T3 (fi) | Vasta-ainekoostumuksia ja niiden käyttömenetelmiä | |
| JP7175506B2 (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| JP2002544174A5 (cg-RX-API-DMAC10.html) | ||
| JP2010511665A5 (cg-RX-API-DMAC10.html) | ||
| FI3990005T3 (fi) | Pegyloitu kystationiini-beta-syntaasi entsyymihoitoa varten homokystinurian hoitamiseksi | |
| JP2022539077A5 (cg-RX-API-DMAC10.html) | ||
| JP2023500032A5 (cg-RX-API-DMAC10.html) | ||
| JP2011506436A (ja) | 細胞傷害性ｔリンパ球抗原４（ｃｔｌａ４）に対する抗体と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法 | |
| UA129431C2 (uk) | Лікування шкірної форми червоного вовчака | |
| US11554156B2 (en) | Pharmaceutical formulations of C1 esterase inhibitor | |
| WO2026011751A1 (zh) | 抗体制剂 | |
| RU2690677C1 (ru) | Стабилизированная композиция, обладающая противовирусной, противоопухолевой, иммуномодулирующей, актопротекторной, антимутагенной и антиоксидантной активностью | |
| NZ541493A (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| CN111432821A (zh) | 治疗细菌感染的方法 | |
| IL312401A (en) | Methods for treating Crohn's disease with a specific anti-IL23 antibody | |
| RU2220730C2 (ru) | Способ лечения герпетического стоматита | |
| US20210386736A1 (en) | Combination therapy for treating cancer | |
| JP3022915B2 (ja) | 癌転移抑制剤 | |
| EP1488800A1 (en) | Agent for the treatment of protozoal diseases | |
| ES2862462B2 (es) | Compuestos para la profilaxis y/o el tratamiento del sindrome de dificultad respiratoria aguda | |
| JP2023550079A5 (cg-RX-API-DMAC10.html) | ||
| JP2023501155A5 (cg-RX-API-DMAC10.html) | ||
| JP2022545553A5 (cg-RX-API-DMAC10.html) |